Thermosome

company

About

Thermosome is developing drug candidates leveraging its proprietary drug delivery technology,

  • 1 - 10

Details

Last Funding Type
Seed
Last Funding Money Raised
€1.90M
Industries
Biopharma,Biotechnology,Medical
Founded date
Jan 1, 2015
Number Of Employee
1 - 10
Operating Status
Active

Thermosome is an emerging biopharmaceutical company headquartered in the Innovation and Start-Up Center for Biotechnology (IZB) in Planegg/Martinsried near Munich, Germany. Our technology was invented by Prof. Dr. Hansjörg Eibl at the Max Planck Institute for Biophysical Chemistry in Göttingen, Germany, and applied, among others, in various in vitro and in vivo studies by a research group at the University Hospital of the Ludwig-Maximilians-Universitaet Munich, Germany. Based on inspiring results from this research including the preclinical proof-of-concept in various animal species, Thermosome started its operational activities in late 2015.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
€1.90M
Thermosome has raised a total of €1.90M in funding over 2 rounds. Their latest funding was raised on Apr 6, 2016 from a Seed round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Apr 6, 2016 Seed €1.90M 1 Detail

Investors

Number of Lead Investors
Number of Investors
1
Thermosome is funded by 1 investors. Bayern Kapital are the most recent investors.
Investor Name Lead Investor Funding Round
Bayern Kapital Seed